Wednesday, April 29, 2026 Lynn Dwernychuk serves as the Director of Clinical Research at the Saskatchewan Cancer Agency and holds an Adjunct Professorship with the College of Graduate Studies and Research at the University of Saskatchewan. In her capacity as Director, Lynn oversees a comprehensive research portfolio that includes both the Allan Blair Cancer Centre in Regina and the Saskatoon Cancer Centre, fostering an environment of innovation and collaboration in cancer research across Saskatchewan.She is the Chair of the Canada Clinical Trials Group (CCTG) Clinical Research Associates Executive Committee, a member of the Canadian Cancer Clinical Trials Network (3CTN) Performance Strategy Sub-Committee, Chair of Canadian Remote Access Framework for Clinical Trials - CRAFT 2.0 Working Group (Inter provincial Trial Collaboration) and holds a position on the Alliance Oncology Nursing Board. Lynn is actively engaged as co-PI in numerous interdisciplinary research projects, clinical trials, and quality improvement initiatives that bring together experts from diverse fields to address pressing challenges in oncology. Her work is featured in peer-reviewed journals, contributing to the scientific community’s understanding of cancer treatment efficacy, patient safety, and quality of life. Lynn is committed to advancing cancer research, improving patient care standards, and supporting the next generation of researchers through mentorship and academic engagement. “I am deeply humbled and truly grateful to be recognized. It is a privilege to lead and work alongside my team and colleagues nationally. We are all united with a shared commitment to improving patient outcomes and advancing care with innovative treatments. I would also like to extend my gratitude to the patients, their courage and willingness to be part of clinical trials are what makes progress possible. Thank you again for this very special recognition, I share it with my team, colleagues and the patients we serve.”
